266 related articles for article (PubMed ID: 20922636)
21. Incidence, case fatality and genotypes causing Clostridium difficile infections, Finland, 2008.
Kotila SM; Virolainen A; Snellman M; Ibrahem S; Jalava J; Lyytikäinen O
Clin Microbiol Infect; 2011 Jun; 17(6):888-93. PubMed ID: 20874814
[TBL] [Abstract][Full Text] [Related]
22. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
Polivkova S; Krutova M; Petrlova K; Benes J; Nyc O
Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates.
Barbut F; Mastrantonio P; Delmée M; Brazier J; Kuijper E; Poxton I;
Clin Microbiol Infect; 2007 Nov; 13(11):1048-57. PubMed ID: 17850341
[TBL] [Abstract][Full Text] [Related]
24. Molecular epidemiology of Clostridium difficile over the course of 10 years in a tertiary care hospital.
Belmares J; Johnson S; Parada JP; Olson MM; Clabots CR; Bettin KM; Peterson LR; Gerding DN
Clin Infect Dis; 2009 Oct; 49(8):1141-7. PubMed ID: 19780659
[TBL] [Abstract][Full Text] [Related]
25. C. difficile infection (CDI) in a long-term acute care facility (LTAC).
Goldstein EJ; Polonsky J; Touzani M; Citron DM
Anaerobe; 2009 Dec; 15(6):241-3. PubMed ID: 19683064
[TBL] [Abstract][Full Text] [Related]
26. Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008.
Kuijper EJ; Barbut F; Brazier JS; Kleinkauf N; Eckmanns T; Lambert ML; Drudy D; Fitzpatrick F; Wiuff C; Brown DJ; Coia JE; Pituch H; Reichert P; Even J; Mossong J; Widmer AF; Olsen KE; Allerberger F; Notermans DW; Delmée M; Coignard B; Wilcox M; Patel B; Frei R; Nagy E; Bouza E; Marin M; Akerlund T; Virolainen-Julkunen A; Lyytikäinen O; Kotila S; Ingebretsen A; Smyth B; Rooney P; Poxton IR; Monnet DL
Euro Surveill; 2008 Jul; 13(31):. PubMed ID: 18761903
[TBL] [Abstract][Full Text] [Related]
27. Clostridium difficile ribotypes 027 and 106: clinical outcomes and risk factors.
Sundram F; Guyot A; Carboo I; Green S; Lilaonitkul M; Scourfield A
J Hosp Infect; 2009 Jun; 72(2):111-8. PubMed ID: 19386381
[TBL] [Abstract][Full Text] [Related]
28. Clostridium difficile infection at a medical center in southern Taiwan: incidence, clinical features and prognosis.
Chung CH; Wu CJ; Lee HC; Yan JJ; Chang CM; Lee NY; Chen PL; Lee CC; Hung YP; Ko WC
J Microbiol Immunol Infect; 2010 Apr; 43(2):119-25. PubMed ID: 20457428
[TBL] [Abstract][Full Text] [Related]
29. Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011.
Chitnis AS; Holzbauer SM; Belflower RM; Winston LG; Bamberg WM; Lyons C; Farley MM; Dumyati GK; Wilson LE; Beldavs ZG; Dunn JR; Gould LH; MacCannell DR; Gerding DN; McDonald LC; Lessa FC
JAMA Intern Med; 2013 Jul; 173(14):1359-67. PubMed ID: 23780507
[TBL] [Abstract][Full Text] [Related]
30. [Clostridium-difficile-associated infections].
Eckert C; Barbut F
Med Sci (Paris); 2010 Feb; 26(2):153-8. PubMed ID: 20188046
[TBL] [Abstract][Full Text] [Related]
31. Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain.
Carignan A; Allard C; Pépin J; Cossette B; Nault V; Valiquette L
Clin Infect Dis; 2008 Jun; 46(12):1838-43. PubMed ID: 18462108
[TBL] [Abstract][Full Text] [Related]
32. Case fatality associated with a hypervirulent strain in patients with culture-positive Clostridium difficile infection: a retrospective population-based study.
Huttunen R; Vuento R; Syrjänen J; Tissari P; Aittoniemi J
Int J Infect Dis; 2012 Jul; 16(7):e532-5. PubMed ID: 22572612
[TBL] [Abstract][Full Text] [Related]
33. Distribution of Clostridium difficile strains from a North American, European and Australian trial of treatment for C. difficile infections: 2005-2007.
Cheknis AK; Sambol SP; Davidson DM; Nagaro KJ; Mancini MC; Hidalgo-Arroyo GA; Brazier JS; Johnson S; Gerding DN
Anaerobe; 2009 Dec; 15(6):230-3. PubMed ID: 19737618
[TBL] [Abstract][Full Text] [Related]
34. Spread and epidemiology of Clostridium difficile polymerase chain reaction ribotype 027/toxinotype III in The Netherlands.
Goorhuis A; Van der Kooi T; Vaessen N; Dekker FW; Van den Berg R; Harmanus C; van den Hof S; Notermans DW; Kuijper EJ
Clin Infect Dis; 2007 Sep; 45(6):695-703. PubMed ID: 17712752
[TBL] [Abstract][Full Text] [Related]
35. Epidemiology of Clostridium difficile in Germany based on a single center long-term surveillance and German-wide genotyping of recent isolates provided to the advisory laboratory for diagnostic reasons.
von Müller L; Mock M; Halfmann A; Stahlmann J; Simon A; Herrmann M
Int J Med Microbiol; 2015 Oct; 305(7):807-13. PubMed ID: 26341328
[TBL] [Abstract][Full Text] [Related]
36. Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland.
Burns K; Morris-Downes M; Fawley WN; Smyth E; Wilcox MH; Fitzpatrick F
J Hosp Infect; 2010 Aug; 75(4):287-91. PubMed ID: 20621236
[TBL] [Abstract][Full Text] [Related]
37. Emergence of reduced susceptibility to metronidazole in Clostridium difficile.
Baines SD; O'Connor R; Freeman J; Fawley WN; Harmanus C; Mastrantonio P; Kuijper EJ; Wilcox MH
J Antimicrob Chemother; 2008 Nov; 62(5):1046-52. PubMed ID: 18693234
[TBL] [Abstract][Full Text] [Related]
38. Effect of metronidazole on growth and toxin production by epidemic Clostridium difficile PCR ribotypes 001 and 027 in a human gut model.
Freeman J; Baines SD; Saxton K; Wilcox MH
J Antimicrob Chemother; 2007 Jul; 60(1):83-91. PubMed ID: 17483547
[TBL] [Abstract][Full Text] [Related]
39. Molecular epidemiology and susceptibility profiles of Clostridium difficile in New Zealand, 2009.
Roberts S; Heffernan H; Al Anbuky N; Pope C; Paviour S; Camp T; Swager T
N Z Med J; 2011 Apr; 124(1332):45-51. PubMed ID: 21747423
[TBL] [Abstract][Full Text] [Related]
40. Nosocomial diarrhea and Clostridium Difficile associated diarrhea in a Turkish University Hospital.
Ergen EK; Akalin H; Yilmaz E; Sinirtaş M; Alver O; Heper Y; Ozakin C; Bakker D; Ener B; Mistik R; Helvaci S; Kuijper EJ
Med Mal Infect; 2009 Jun; 39(6):382-7. PubMed ID: 19269761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
